Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  2,885 results for ""Designer Drugs""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Designer drugs.
Research Starter

Designer drugs.

  • DEFINITION: Designer drugs are illegal synthetic analogs of controlled substances that possess similar pharmacological qualities. Designer drugs encompass a wide ... More
  • Salem Press Encyclopedia of Health, 2025. 3p.
Academic Journal

Clozapine N-oxide, compound 21, and JHU37160 do not influence effortful reward-seeking behavior in mice.

  • Authors : Aomine Y; Laboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.; Department of Biological Sciences, Graduate School of Science, Osaka University, Toyonaka, Osaka, Japan.

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacology ; Designer Drugs*/Designer Drugs*/Designer Drugs*/pharmacology; Mice

  • Source: Psychopharmacology [Psychopharmacology (Berl)] 2024 Jan; Vol. 241 (1), pp. 89-96. Date of Electronic Publication: 2023 Oct 04.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Inhibition of RtTg neurons reverses methamphetamine-induced attention deficits.

  • Source: Acta Neuropathologica Communications. 11/22/2024, Vol. 12 Issue 1, p1-15. 15p.

Record details

×
Academic Journal

Hallucinating hallucinogens.

  • Authors : Skinnider MA; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.

Subjects: Artificial Intelligence* ; Designer Drugs*/Designer Drugs*/Designer Drugs*/chemistry ; Designer Drugs*/Designer Drugs*/Designer Drugs*/toxicity

  • Source: Science (New York, N.Y.) [Science] 2023 Nov 10; Vol. 382 (6671), pp. 656-657. Date of Electronic Publication: 2023 Nov 09.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic

Record details

×
Academic Journal

Forensic Aspects of Designer LSD Analogs Identification by GC-MS (EI) and UV Spectroscopy.

  • Authors : Tusiewicz K; Institute of Toxicology Research, 45 Kasztanowa Street, 55-093 Borowa, Poland.; Wachełko O

Subjects: Gas Chromatography-Mass Spectrometry*/Gas Chromatography-Mass Spectrometry*/Gas Chromatography-Mass Spectrometry*/methods ; Lysergic Acid Diethylamide*/Lysergic Acid Diethylamide*/Lysergic Acid Diethylamide*/analogs & derivatives ; Lysergic Acid Diethylamide*/Lysergic Acid Diethylamide*/Lysergic Acid Diethylamide*/chemistry

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Dec 04; Vol. 29 (23). Date of Electronic Publication: 2024 Dec 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

Flualprazolam and flubromazolam: Blood concentrations and prevalence of two novel psychoactive substances in forensic case work in Ontario, Canada.

Subjects: Designer Drugs*; Humans ; Ontario

  • Source: Journal of analytical toxicology [J Anal Toxicol] 2023 Nov 01; Vol. 47 (8), pp. 762-769.Publisher: Oxford University Press Country of Publication: England NLM ID: 7705085 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition.

  • Authors : Lawson KA; Department of Neurobiology and Behavior, University of California Irvine, 1132 McGaugh Hall, Irvine, CA, 92697, USA. .; Ruiz CM

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacology ; Designer Drugs*; Rats

  • Source: Psychopharmacology [Psychopharmacology (Berl)] 2023 Oct; Vol. 240 (10), pp. 2101-2110. Date of Electronic Publication: 2023 Aug 02.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  2,885 results for ""Designer Drugs""